Chronic psychosis associated with new hallucinogenic drug 25I-NBOMe
European Psychiatry October 23, 2023 O. Martin-Santiago, G. Guerra-Valera, C. Alario-Ruiz et al.
Introduction The presence of perceptual disturbances and psychotic symptoms associated with substance abuse are widely known. While the abuse of substances is becoming more widespread, there is a general perception that their use entails fewer risks. 25I-NBOMe is a recently introduced hallucinogenic drug producing visual hallucinations and euphoria. Although people consume it like LSD, its...